Profile: KMT Hepatech, Inc. provides collaborative research services to companies who are in the pre-clinical development of hepatitis C therapeutics and vaccines. Our KMT Mouse™ is a robust small animal model for hepatitis C drug discovery, development and pre-clinical studies. Our experimental animals provide an authentic viral infection model utilizing transplanted human hepatocytes in a true in-vivo setting. We perform scientific evaluation services in the areas of safety & toxicity, pharmacokinetics, anti-viral effect, combination therapies & strategies, protective capability of vaccines/therapeutic immunoglogbulin, dose escalation & dose-related responses, viral resistance and other liver-affinity pathogen studies.